دورية أكاديمية
Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research.
| العنوان: | Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research. |
|---|---|
| المؤلفون: | Paudyal V; School of Pharmacy, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham United Kingdom. Electronic address: v.paudyal@bham.ac.uk., Sun S; College of Pharmacy and Health Sciences, Western New England University, United States; Xuangya Hospital of Central South University, Hunan, China., Hussain R; Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan., Abutaleb MH; Pharmacy Department, King Fahad Central Hospital-Jazan Health Afairs, Ministryof Health, Jazan, Saudi Arabia., Hedima EW; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Gombe State University, Nigeria. |
| المصدر: | Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2022 Mar; Vol. 18 (3), pp. 2524-2528. Date of Electronic Publication: 2021 May 13. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 101231974 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1934-8150 (Electronic) Linking ISSN: 15517411 NLM ISO Abbreviation: Res Social Adm Pharm Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, NY : Elsevier |
| مواضيع طبية MeSH: | COVID-19* , Complementary Therapies*, Humans ; Pandemics ; Policy ; SARS-CoV-2 |
| مستخلص: | The COVID-19 pandemic has met international health systems with a low level of preparedness and emergency response. While the emergence of effective vaccines has offered the Governments, scientific communities, and members of the public a possible way out of the pandemic, effective pharmacotherapy, including immunotherapy for COVID-19 prevention and treatment, are yet to be established. Internationally, this has led to a surge in the demand and supply of many complementary and alternative medicines (CAM) and practices. Recent studies have shown increasing CAM information requests made to pharmacists and other healthcare staff from members of public and patients aimed at prevention, symptoms relief or treatment of COVID-19. In this context, it is imperative that healthcare professionals, including pharmacists, are acquainted with current practices, policies, and research in relation to CAM use in COVID-19. This narrative commentary will provide an update on global practices, policies and research in regards to CAM use in the context of COVID-19. Healthcare professionals' understanding of popular CAMs and those tipped for potential benefits in COVID-19, patient and consumer behaviors in relation to CAM use; and healthcare professionals' awareness of cultural, religious, and self-care practices associated with CAM use are imperative to inform effective communication and counselling practices and promote evidence based self-care when patients present for advice. This narrative provides relevant discussions specific to different continents and regions historically linked to diverse CAM practices. (Copyright © 2021 Elsevier Inc. All rights reserved.) |
| References: | Biomed Pharmacother. 2020 Nov;131:110622. (PMID: 32890967) Pharmacol Res. 2021 Apr;166:105472. (PMID: 33592272) Am J Blood Res. 2020 Oct 15;10(5):266-282. (PMID: 33224571) Ann Intern Med. 2020 Oct 20;173(8):623-631. (PMID: 32673060) Evid Based Complement Alternat Med. 2020 Oct 10;2020:2560645. (PMID: 33101440) Am J Blood Res. 2020 Dec 15;10(6):397-406. (PMID: 33489449) J Am Coll Clin Pharm. 2020 Aug;3(5):866-868. (PMID: 32838220) Res Social Adm Pharm. 2014 Jan-Feb;10(1):88-105. (PMID: 23665077) Indian J Clin Biochem. 2021 Jan;36(1):108-111. (PMID: 33162692) Integr Med Res. 2020 Sep;9(3):100473. (PMID: 32766112) Lancet Infect Dis. 2021 Jan;21(1):20-21. (PMID: 33248473) J Pharmacopuncture. 2020 Jun 30;23(2):62-70. (PMID: 32685234) Front Pharmacol. 2020 Sep 23;11:581840. (PMID: 33071794) Indian J Microbiol. 2021 Mar;61(1):10-15. (PMID: 33390627) N Engl J Med. 2021 Feb 25;384(8):693-704. (PMID: 32678530) Adv Integr Med. 2021 Dec;8(4):247-255. (PMID: 34395188) Pharmacol Ther. 2020 Oct;214:107618. (PMID: 32592716) Sci Afr. 2020 Nov;10:e00620. (PMID: 33163740) Eur J Clin Pharmacol. 2021 Sep;77(9):1259-1274. (PMID: 33686454) Evid Based Complement Alternat Med. 2013;2013:617459. (PMID: 24367388) J Altern Complement Med. 2009 May;15(5):545-50. (PMID: 19422284) Res Social Adm Pharm. 2021 Aug;17(8):1507-1517. (PMID: 33288420) J Biomol Struct Dyn. 2022 Jan;40(1):190-203. (PMID: 32851919) Int J Clin Pharm. 2021 Feb;43(1):35-45. (PMID: 32974857) Saudi Pharm J. 2020 Nov;28(11):1326-1332. (PMID: 32904846) Phytomed Plus. 2021 Aug;1(3):100043. (PMID: 35399823) Int J Clin Pharm. 2012 Oct;34(5):733-8. (PMID: 22740232) Evid Based Complement Alternat Med. 2005 Jun;2(2):139-142. (PMID: 15937553) PLoS One. 2018 Oct 4;13(10):e0205087. (PMID: 30286166) Pharmaceut Med. 2018;32(1):39-49. (PMID: 29456449) |
| فهرسة مساهمة: | Keywords: CAM; COVID-19; Complementary and alternative medicines; Herbal medicines; Patient education and counselling |
| تواريخ الأحداث: | Date Created: 20210516 Date Completed: 20220210 Latest Revision: 20221221 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC8116135 |
| DOI: | 10.1016/j.sapharm.2021.05.004 |
| PMID: | 33992585 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!